Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
In connection with the IPO, on March 22, 2021, Gareth Penny, Thando Mhlambiso and Ziyanda Ntshona (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”). The Board has determined that Mr. Penny, Mr. Mhlambiso and Ms. Ntshona are independent directors within the meaning of applicable SEC and NASDAQ rules. Effective March 22, 2021, Mr. Penny, Mr. Mhlambiso and Ms. Ntshona were appointed to the Board’s Audit Committee, with Mr. Mhlambiso serving as chair of the Audit Committee. Effective March 22, 2021, Mr. Penny, Mr. Mhlambiso and Ms. Ntshona were appointed to the Board’s Human Capital Committee, with Mr. Penny serving as chair of the Human Capital Committee. Effective March 22, 2021, Mr. Penny, Mr. Mhlambiso and Ms. Ntshona were appointed to the Board’s Nominating Committee, with Ms. Ntshona serving as chair of the Nominating Committee.
Following the appointment of the Directors, the Board is comprised of the following three classes: the term of office of the first class of directors, consisting of Ziyanda Ntshona, will expire at our first annual general meeting; the term of office of the second class of directors, consisting of Thando Mhlambiso, will expire at the second annual general meeting; and the term of office of the third class of directors, consisting of Gareth Penny and Andrew Rolfe, will expire at the third annual general meeting.
On March 22, 2021, in connection with his or her appointment to the Board, each Director entered into the Letter Agreement as well as an indemnity agreement with the Company in the form previously filed as Exhibit 10.8 to the Registration Statement.
Other than the foregoing, none of the Directors are party to any arrangement or understanding with any person pursuant to which they were appointed as directors nor are they party to any transactions required to be disclosed under Item 404(a) of Regulation S-K involving the Company.
The foregoing descriptions of the Letter Agreement and the form of indemnity agreement do not purport to be complete and are qualified in their entireties by reference to the Letter Agreement and form of indemnity agreement, copies of which are attached as Exhibit 10.8 hereto and Exhibit 10.4 to the Registration Statement, respectively, and are incorporated herein by reference.
Item 5.03. Amendments to Certificate of Incorporation or Bylaws; Change in Fiscal Year.
On March 22, 2021, in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association (the “Amended Charter”), effective the same day. The terms of the Amended Charter are set forth in the Registration Statement and are incorporated herein by reference. A copy of the Amended Charter is attached as Exhibit 3.2 hereto and incorporated herein by reference.
Item 8.01. Other Events.
A total of $200,000,000, comprised of $196,000,000 of the proceeds from the IPO (which amount includes $7,000,000 of the underwriters’ deferred discount) and $4,000,000 of the proceeds of the sale of the Private Placement Warrants, was placed in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A. maintained by Continental Stock Transfer & Trust Company, acting as trustee. On March 23, 2021, the Company issued a press release announcing the pricing of the IPO, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.